关注
William Wilson
William Wilson
CSIRO Health and Biosecurity
在 csiro.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway
PJ Kallio, WJ Wilson, S O’Brien, Y Makino, L Poellinger
Journal of Biological Chemistry 274 (10), 6519-6525, 1999
11291999
Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3α locus
Y Makino, A Kanopka, WJ Wilson, H Tanaka, L Poellinger
Journal of Biological Chemistry 277 (36), 32405-32408, 2002
5562002
ACCELERATED PUBLICATIONS-Inhibitory PAS Domain Protein (IPAS) Is a Hypoxia-inducible Splicing Variant of the Hypoxia-inducible Factor-3a Locus.
Y Makino, A Kanopka, WJ Wilson, H Tanaka, L Poellinger
Journal of Biological Chemistry 277 (36), 32405-32408, 2002
556*2002
Extending thrombolysis to 4· 5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
BCV Campbell, H Ma, PA Ringleb, MW Parsons, L Churilov, M Bendszus, ...
The Lancet 394 (10193), 139-147, 2019
4812019
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
4722012
Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
Z Stark, D Schofield, K Alam, W Wilson, N Mupfeki, I Macciocca, ...
Genetics in Medicine 19 (8), 867-874, 2017
2382017
Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains
A Bratt, WJ Wilson, B Troyanovsky, K Aase, R Kessler, EGV Meir, ...
Gene 298 (1), 69-77, 2002
1582002
A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study
SC Burnham, NG Faux, W Wilson, SM Laws, D Ames, J Bedo, AI Bush, ...
Molecular psychiatry 19 (4), 519-526, 2014
1282014
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease
P Johnson, L Vandewater, W Wilson, P Maruff, G Savage, P Graham, ...
BMC bioinformatics 15 (S16), S11, 2014
1162014
An increased neutrophil–lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation
A Rembach, AD Watt, WJ Wilson, S Rainey-Smith, KA Ellis, CC Rowe, ...
Journal of neuroimmunology 273 (1-2), 65-71, 2014
1042014
Characterization of a novel B‐CLL candidate gene–DLEU7–located in the 13q14 tumor suppressor locus
M Hammarsund, MM Corcoran, W Wilson, C Zhu, S Einhorn, O Sangfelt, ...
FEBS letters 556 (1-3), 75-80, 2004
842004
Identification and characterization of two novel human mitochondrial elongation factor genes, hEFG2 and hEFG1, phylogenetically conserved through evolution
M Hammarsund, W Wilson, M Corcoran, M Merup, S Einhorn, D Grandér, ...
Human genetics 109 (5), 542-550, 2001
842001
The dietary flavonoid quercetin modulates HIF-1α activity in endothelial cells
WJ Wilson, L Poellinger
Biochemical and biophysical research communications 293 (1), 446-450, 2002
832002
DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse
MM Corcoran, M Hammarsund, C Zhu, M Lerner, B Kapanadze, B Wilson, ...
Genes, Chromosomes and Cancer 40 (4), 285-297, 2004
602004
Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease
A Rembach, JD Doecke, BR Roberts, AD Watt, NG Faux, I Volitakis, ...
Journal of Alzheimer's Disease 34 (1), 171-182, 2013
592013
Altered metabolism of growth hormone receptor mutant mice: a combined NMR metabonomics and microarray study
HJ Schirra, CG Anderson, WJ Wilson, L Kerr, DJ Craik, MJ Waters, ...
PloS one 3 (7), e2764, 2008
592008
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing …
KA Ellis, C Szoeke, AI Bush, D Darby, PL Graham, NT Lautenschlager, ...
International Psychogeriatrics 26 (4), 543-554, 2014
522014
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
A Rembach, AD Watt, WJ Wilson, VL Villemagne, SC Burnham, KA Ellis, ...
Journal of Alzheimer's disease: JAD 40 (1), 95-104, 2013
492013
Predicting Alzheimer disease from a blood-based biomarker profile A 54-month follow-up
SC Burnham, CC Rowe, D Baker, AI Bush, JD Doecke, NG Faux, ...
Neurology 87 (11), 1093-1101, 2016
362016
O3‐13‐01: RETINAL AMYLOID FLUORESCENCE IMAGING PREDICTS CEREBRAL AMYLOID BURDEN AND ALZHEIMER'S DISEASE
S Frost, Y Kanagasingam, L Macaulay, M Koronyo‐Hamaoui, Y Koronyo, ...
Alzheimer's & Dementia 10, P234-P235, 2014
342014
系统目前无法执行此操作,请稍后再试。
文章 1–20